Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Merino DM"'
Autor:
Hall AG; Division of Hematology and Oncology, University of Washington, Seattle Children's Hospital, Seattle, Washington; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington. Electronic address: Anurekha.Hall@seattlechildrens.org., Winestone LE; Division of Pediatric Allergy, Immunology, and Blood & Marrow Transplantation, UCSF Benioff Children's Hospitals, San Francisco, California., Sullivan EM; Core for Biostatistics, Epidemiology, and Analytics in Research, Seattle Children's Research Institute, Seattle, Washington., Wu Q; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington., Lamble AJ; Division of Hematology and Oncology, University of Washington, Seattle Children's Hospital, Seattle, Washington., Walters MC; Division of Oncology, UCSF Benioff Children's Hospitals, Oakland, California., Aguayo-Hiraldo P; Cancer and Blood Disease Institute, Children's Hospital Los Angeles, Los Angeles, California; USC Norris Comprehensive Cancer Center, University of Southern California, Keck School of Medicine, Los Angeles, California., Baez Conde L; USC Norris Comprehensive Cancer Center, University of Southern California, Keck School of Medicine, Los Angeles, California., Coker TR; Department of Pediatrics, Seattle Children's Research Institute, University of Washington School of Medicine, Seattle, Washington., Dornsife D; Lazarex Foundation, Danville, California., Keating AK; Pediatric Blood and Marrow Transplantation, University of Colorado School of Medicine, Aurora, Colorado., Merino DM; Friends of Cancer Research, Washington, DC., Ramsey B; Department of Pediatrics, Seattle Children's Hospital, University of Washington School of Medicine, Seattle, Washington., Park JR; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee., Agrawal AK; Division of Oncology, UCSF Benioff Children's Hospitals, Oakland, California.
Publikováno v:
Transplantation and cellular therapy [Transplant Cell Ther] 2023 Jun; Vol. 29 (6), pp. 356.e1-356.e7. Date of Electronic Publication: 2023 Mar 24.
Autor:
LeBlanc TW; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, USA., Russell NH; Department of Haematology, Guy's Hospital, London, UK., Hernandez-Aldama L; ArmorUp for LIFE, Philadelphia, USA., Panter C; Adelphi Values Patient-Centered Outcomes, Cheshire, UK. charlotte.panter@adelphivalues.com., Bell TJ; Pfizer Inc., New York, USA., Welch V; Pfizer Inc., New York, USA., Vega DM; Friends of Cancer Research, Washington, DC, USA., O'Hara L; Adelphi Values Patient-Centered Outcomes, Cheshire, UK., Stein J; Adelphi Values Patient-Centered Outcomes, Cheshire, UK., Barclay M; Adelphi Values Patient-Centered Outcomes, Cheshire, UK., Peloquin F; Pfizer Canada ULC, Kirkland, Canada., Brown A; Pfizer Ltd, Tadworth, UK., Healy J; Pfizer Canada ULC, Kirkland, Canada., Morgan L; Adelphi Values Patient-Centered Outcomes, Cheshire, UK., Gater A; Adelphi Values Patient-Centered Outcomes, Cheshire, UK., Hohman R; Friends of Cancer Research, Washington, DC, USA., Amer K; Pfizer Ltd, Tadworth, UK., Maze D; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Walter RB; Fred Hutchinson Cancer Research Center, Seattle, USA.
Publikováno v:
Oncology and therapy [Oncol Ther] 2022 Dec; Vol. 10 (2), pp. 421-440. Date of Electronic Publication: 2022 Jun 13.
Autor:
Vega DM; Friends of Cancer Research, Washington, DC., Nishimura KK; Cancer Research And Biostatistics (CRAB), Seattle, WA., Zariffa N; NMD Group LLC, Bala Cynwyd, PA., Thompson JC; Division of Pulmonary, Allergy and Critical Care Medicine, Thoracic Oncology Group, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA., Hoering A; Cancer Research And Biostatistics (CRAB), Seattle, WA., Cilento V; Cancer Research And Biostatistics (CRAB), Seattle, WA., Rosenthal A; Cancer Research And Biostatistics (CRAB), Seattle, WA., Anagnostou V; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD., Baden J; Translational Medicine, Bristol Myers Squibb, Princeton, NJ., Beaver JA; Oncology Center of Excellence, Food and Drug Administration (FDA), Silver Spring, MD., Chaudhuri AA; Department of Radiation Oncology, Washington University School of Medicine, St Louis, MO.; Department of Genetics, Washington University School of Medicine, St Louis, MO.; Department of Computer Science and Engineering, Washington University, St Louis, MO.; Siteman Cancer Center, Washington University School of Medicine, St Louis, MO., Chudova D; Guardant Health Inc, Redwood City, CA., Fine AD; Research and Development, Foundation Medicine Inc, Cambridge, MA., Fiore J; Oncology Development, Bristol Myers Squibb, Princeton, NJ., Hodge R; Late Oncology Statistics, Oncology Biometrics, AstraZeneca, Cambridge, United Kingdom., Hodgson D; Translational Medicine, Oncology Research & Development, AstraZeneca, Waltham, MA., Hunkapiller N; GRAIL, Menlo Park, CA.; During the conduct of this work and development of the manuscript, N.H. was affiliated with GRAIL, Inc; however, is not affiliated with GRAIL, Inc at the time of submission., Klass DM; Assay Development, Roche Sequencing Solutions, Pleasanton, CA., Kobie J; Translational Oncology, Early Oncology Statistics, Merck Research Laboratories, Kenilworth, NJ., Peña C; Companion Diagnostics, Oncology Early Development, Merck Research Laboratories, Kenilworth, NJ., Pennello G; Division of Imaging, Diagnostics, and Software Reliability, Office of Science and Engineering Laboratories, Food and Drug Administration (FDA), Silver Spring, MD., Peterman N; Foundation Medicine Inc, San Diego, CA., Philip R; Division of Molecular Genetics, Office of Health Technology 7 (In Vitro Diagnostics and Radiological Health), Food and Drug Administration (FDA), Silver Spring, MD., Quinn KJ; Guardant Health Inc, Redwood City, CA., Raben D; Product Development Oncology, Genentech Inc, South San Francisco, CA., Rosner GL; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD., Sausen M; Translational Medicine, Bristol Myers Squibb, Princeton, NJ., Tezcan A; Foundation Medicine Inc, San Diego, CA., Xia Q; Product Development Data Sciences, Genentech Inc, South San Francisco, CA., Yi J; Product Development Oncology, Genentech Inc, South San Francisco, CA., Young AG; Research and Development, Foundation Medicine Inc, Cambridge, MA., Stewart MD; Friends of Cancer Research, Washington, DC., Carpenter EL; Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA., Aggarwal C; Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA., Allen J; Friends of Cancer Research, Washington, DC.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2022 Aug; Vol. 6, pp. e2100372.
Autor:
Kim ES; City of Hope Orange County and National Medical Center, Los Angeles, California. edwkim@coh.org., Uldrick TS; Fred Hutchinson Cancer Research Center, Seattle, Washington., Schenkel C; American Society of Clinical Oncology, Alexandria, Virginia., Bruinooge SS; American Society of Clinical Oncology, Alexandria, Virginia., Harvey RD; Emory University School of Medicine, Atlanta, Georgia., Magnuson A; University of Rochester, Rochester, New York., Spira A; Virginia Cancer Specialists PC, Fairfax, Virginia., Wade JL; Cancer Care Specialists of Illinois, Decatur, Illinois., Stewart MD; Friends of Cancer Research, Washington, DC., Vega DM; Friends of Cancer Research, Washington, DC., Beaver JA; U.S. Food and Drug Administration, Silver Spring, Maryland., Denicoff AM; National Cancer Institute, Bethesda, Maryland., Ison G; U.S. Food and Drug Administration, Silver Spring, Maryland., Ivy SP; National Cancer Institute, Bethesda, Maryland., George S; Dana-Farber Cancer Institute, Boston, Massachusetts., Perez RP; Bristol-Myers Squibb, Lawrenceville, New Jersey., Spears PA; UNC Patient Advocates for Research Council, Raleigh, North Carolina., Tap WD; Memorial Sloan Kettering Cancer Center, New York, New York., Schilsky RL; American Society of Clinical Oncology, Alexandria, Virginia.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 May 01; Vol. 27 (9), pp. 2394-2399. Date of Electronic Publication: 2021 Feb 09.
Autor:
Osarogiagbon RU; Multidisciplinary Thoracic Oncology Program, Baptist Cancer Center, Memphis, Tennessee. rosarogi@bmhcc.org., Vega DM; Friends of Cancer Research, Washington, DC., Fashoyin-Aje L; U.S. Food and Drug Administration, Silver Spring, Maryland., Wedam S; U.S. Food and Drug Administration, Silver Spring, Maryland., Ison G; U.S. Food and Drug Administration, Silver Spring, Maryland., Atienza S; Advocate Aurora Health, Milwaukee, Wisconsin., De Porre P; Janssen Pharmaceutica, Beerse, Belgium., Biswas T; University Hospitals Seidman Cancer Center, Cleveland, Ohio., Holloway JN; Patient Advocate, Arlington, Virginia., Hong DS; MD Anderson Cancer Center, Houston, Texas., Wempe MM; Friends of Cancer Research, Washington, DC., Schilsky RL; American Society of Clinical Oncology, Alexandria, Virginia., Kim ES; Levine Cancer Institute, Atrium Health, Charlotte, North Carolina., Wade JL 3rd; Cancer Care Specialists of Central Illinois, Decatur, Illinois.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 May 01; Vol. 27 (9), pp. 2408-2415. Date of Electronic Publication: 2021 Feb 09.
Autor:
Morton LM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD., Karyadi DM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD., Hartley SW; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD., Frone MN; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD., Sampson JN; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD., Howell RM; Department of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, TX., Neglia JP; Department of Pediatrics, University of Minnesota, Minneapolis, MN., Arnold MA; Department of Pathology and Laboratory Medicine, Nationwide Children's Hospital, Columbus, OH.; Department of Pathology, Wexner Medical Center, Ohio State University, Columbus, OH., Hicks BD; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD.; Cancer Genomics Research Laboratory, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD., Jones K; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD.; Cancer Genomics Research Laboratory, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD., Zhu B; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD.; Cancer Genomics Research Laboratory, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD., Dagnall CL; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD.; Cancer Genomics Research Laboratory, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD., Karlins E; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD.; Cancer Genomics Research Laboratory, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD., Yeager MS; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD.; Cancer Genomics Research Laboratory, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD., Leisenring WM; Cancer Prevention and Clinical Statistics Programs, Fred Hutchinson Cancer Research Center, Seattle, WA., Yasui Y; Department of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, TN., Turcotte LM; Department of Pediatrics, University of Minnesota, Minneapolis, MN., Smith SA; Department of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, TX., Weathers RE; Department of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, TX., Miller J; Information Management Services, Calverton, MD., Sigel BS; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD., Merino DM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD., Berrington de Gonzalez A; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD., Bhatia S; Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL., Robison LL; Department of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, TN., Tucker MA; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD., Armstrong GT; Department of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, TN., Chanock SJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2020 Aug 21; Vol. 4. Date of Electronic Publication: 2020 Aug 21 (Print Publication: 2020).
Autor:
Wempe MM; Research Associate, Friends of Cancer Research, Washington, DC., Stewart MD; Vice President, Science Policy, Friends of Cancer Research, Washington, DC., Glass D; Managing Director, Global Market Research, Deerfield Management, New York, NY., Lasiter L; Director, Health Policy, Friends of Cancer Research, Washington, DC., Vega DM; Director, Research Partnerships, Friends of Cancer Research, Washington, DC., Ramamurthy N; Summer Intern, Friends of Cancer Research, Washington, DC., Allen J; President and CEO, Friends of Cancer Research, Washington, DC., Sigal EV; Chairperson and Founder, Friends of Cancer Research, Washington, DC.
Publikováno v:
American health & drug benefits [Am Health Drug Benefits] 2020 Jun; Vol. 13 (3), pp. 110-119.
Autor:
Merino DM; Friends of Cancer Research, Washington, DC, USA dmerino@focr.org., McShane LM; National Cancer Institute, Bethesda, Maryland, USA., Fabrizio D; Foundation Medicine Inc, Cambridge, Massachusetts, USA., Funari V; NeoGenomics Laboratories, Aliso Viejo, California, USA., Chen SJ; ACT Genomics, Taipei, Taiwan., White JR; Resphera Biosciences, Baltimore, Maryland, USA., Wenz P; Clinical Genomics, Illumina Inc, San Diego, California, USA., Baden J; Bristol-Myers Squibb Co, Princeton, New Jersey, USA., Barrett JC; Translational Medicine, Oncology Research and Early Development, AstraZeneca Pharmaceuticals LP, Boston, Massachusetts, USA., Chaudhary R; Clinical Sequencing Division, Thermo Fisher Scientific, Ann Arbor, Michigan, USA., Chen L; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Chen WS; Caris Life Sciences Inc, Phoenix, Arizona, USA., Cheng JH; ACT Genomics, Taipei, Taiwan., Cyanam D; Clinical Sequencing Division, Thermo Fisher Scientific, Ann Arbor, Michigan, USA., Dickey JS; Personal Genome Diagnostics, Baltimore, Maryland, USA., Gupta V; QIAGEN Inc, Aarhus, Denmark., Hellmann M; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Helman E; Bioinformatics, Guardant Health Inc, Redwood City, California, USA., Li Y; Foundation Medicine Inc, Cambridge, Massachusetts, USA., Maas J; Quality in Pathology (QuIP), Berlin, Germany., Papin A; QIAGEN Inc, Waltham, Massachusetts, USA., Patidar R; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Quinn KJ; Bioinformatics, Guardant Health Inc, Redwood City, California, USA., Rizvi N; Division of Hematology/Oncology, Department of Medicine, Columbia University, New York, New York, USA., Tae H; Caris Life Sciences Inc, Phoenix, Arizona, USA., Ward C; Bristol-Myers Squibb Co, Princeton, New Jersey, USA., Xie M; AstraZeneca Pharmaceuticals LP, Waltham, Massachusetts, USA., Zehir A; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Zhao C; Clinical Genomics, Illumina Inc, San Diego, California, USA., Dietel M; Quality in Pathology (QuIP), Berlin, Germany., Stenzinger A; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Baden-Württemberg, Germany., Stewart M; Friends of Cancer Research, Washington, DC, USA., Allen J; Friends of Cancer Research, Washington, DC, USA.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2020 Mar; Vol. 8 (1).
Autor:
Kazdal D; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany; Translational Lung Research Center (TLRC) Heidelberg, German Center for Lung Research (DZL), Heidelberg, Germany., Endris V; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany., Allgäuer M; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany., Kriegsmann M; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany., Leichsenring J; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany., Volckmar AL; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany., Harms A; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany; Translational Lung Research Center (TLRC) Heidelberg, German Center for Lung Research (DZL), Heidelberg, Germany., Kirchner M; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany., Kriegsmann K; Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany., Neumann O; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany., Brandt R; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany., Talla SB; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany., Rempel E; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany., Ploeger C; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany., von Winterfeld M; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany., Christopoulos P; Translational Lung Research Center (TLRC) Heidelberg, German Center for Lung Research (DZL), Heidelberg, Germany; Department of Thoracic Oncology, Thoraxklinik at the University Hospital Heidelberg, Heidelberg, Germany., Merino DM; Friends of Cancer Research, Washington, DC., Stewart M; Friends of Cancer Research, Washington, DC., Allen J; Friends of Cancer Research, Washington, DC., Bischoff H; Translational Lung Research Center (TLRC) Heidelberg, German Center for Lung Research (DZL), Heidelberg, Germany; Department of Thoracic Oncology, Thoraxklinik at the University Hospital Heidelberg, Heidelberg, Germany., Meister M; Translational Lung Research Center (TLRC) Heidelberg, German Center for Lung Research (DZL), Heidelberg, Germany; Translational Research Unit, Thoraxklinik at University Hospital Heidelberg, Heidelberg, Germany., Muley T; Translational Research Unit, Thoraxklinik at University Hospital Heidelberg, Heidelberg, Germany., Herth F; Translational Lung Research Center (TLRC) Heidelberg, German Center for Lung Research (DZL), Heidelberg, Germany; Department of Pneumonology and Critical Care Medicine, Thoraxklinik at the University Hospital Heidelberg, Germany., Penzel R; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany., Warth A; Institute of Pathology, Cytopathology, and Molecular Pathology UEGP MVZ Giessen/ Wetzlar/Limburg, Germany., Winter H; Translational Lung Research Center (TLRC) Heidelberg, German Center for Lung Research (DZL), Heidelberg, Germany; Department of Thoracic Surgery, Thoraxklinik at the University Hospital Heidelberg, Heidelberg, Germany., Fröhling S; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), Heidelberg, Germany; German Cancer Consortium (DKTK), Partner Site, Heidelberg, Germany., Peters S; Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV) and Lausanne University, Lausanne, Switzerland., Swanton C; Cancer Evolution and Genome Instability Translational Cancer Therapeutics Laboratory, Francis Crick Institute, London, United Kingdom., Thomas M; Translational Lung Research Center (TLRC) Heidelberg, German Center for Lung Research (DZL), Heidelberg, Germany; Department of Thoracic Oncology, Thoraxklinik at the University Hospital Heidelberg, Heidelberg, Germany., Schirmacher P; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany; German Cancer Consortium (DKTK), Partner Site, Heidelberg, Germany., Budczies J; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany., Stenzinger A; Translational Lung Research Center (TLRC) Heidelberg, German Center for Lung Research (DZL), Heidelberg, Germany; German Cancer Consortium (DKTK), Partner Site, Heidelberg, Germany. Electronic address: albrecht.stenzinger@med.uni-heidelberg.de.
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2019 Nov; Vol. 14 (11), pp. 1935-1947. Date of Electronic Publication: 2019 Jul 23.
Autor:
Pienkowska M; Genetics and Genome Biology Program, Hospital for Sick Children, PGCRL, 686 Bay Street, Toronto, Ontario, M5G 0A4, Canada., Choufani S; Genetics and Genome Biology Program, Hospital for Sick Children, PGCRL, 686 Bay Street, Toronto, Ontario, M5G 0A4, Canada., Turinsky AL; Genetics and Genome Biology Program, Hospital for Sick Children, PGCRL, 686 Bay Street, Toronto, Ontario, M5G 0A4, Canada.; Center for Computational Medicine, Hospital for Sick Children, PGCRL, 686 Bay Street, Toronto, Ontario, M5G 0A4, Canada., Guha T; Genetics and Genome Biology Program, Hospital for Sick Children, PGCRL, 686 Bay Street, Toronto, Ontario, M5G 0A4, Canada., Merino DM; Friends of Cancer Research, 1800 M Street, NW, Suite 1050 South, Washington, DC, 20036, USA., Novokmet A; Genetics and Genome Biology Program, Hospital for Sick Children, PGCRL, 686 Bay Street, Toronto, Ontario, M5G 0A4, Canada., Brudno M; Genetics and Genome Biology Program, Hospital for Sick Children, PGCRL, 686 Bay Street, Toronto, Ontario, M5G 0A4, Canada.; Center for Computational Medicine, Hospital for Sick Children, PGCRL, 686 Bay Street, Toronto, Ontario, M5G 0A4, Canada.; Department of Computer Science, University of Toronto, 40 St. George Street, Toronto, Ontario, M5S 2E4, Canada., Weksberg R; Genetics and Genome Biology Program, Hospital for Sick Children, PGCRL, 686 Bay Street, Toronto, Ontario, M5G 0A4, Canada.; Division of Clinical and Metabolic Genetics, Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, M5G 1X8, Canada.; Department of Pediatrics, Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, M5G 1X8, Canada., Shlien A; Genetics and Genome Biology Program, Hospital for Sick Children, PGCRL, 686 Bay Street, Toronto, Ontario, M5G 0A4, Canada.; Paediatric Laboratory Medicine, Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, M5G 1X8, Canada., Hawkins C; Genetics and Genome Biology Program, Hospital for Sick Children, PGCRL, 686 Bay Street, Toronto, Ontario, M5G 0A4, Canada.; Paediatric Laboratory Medicine, Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, M5G 1X8, Canada., Bouffet E; Division of Hematology/Oncology, Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, M5G 1X8, Canada.; Department of Pediatrics, Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, M5G 1X8, Canada., Tabori U; Genetics and Genome Biology Program, Hospital for Sick Children, PGCRL, 686 Bay Street, Toronto, Ontario, M5G 0A4, Canada.; Division of Hematology/Oncology, Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, M5G 1X8, Canada.; Department of Pediatrics, Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, M5G 1X8, Canada., Gilbertson RJ; Department of Oncology, Cambridge Cancer Center, Robinson Way, Cambridge, CB2 0RE, England., Finlay JL; Neuro-Oncology Program, Nationwide Children's Hospital and The Ohio State University, 700 Children's Dr, Columbus, OH, 43205, USA., Jabado N; Division of Hematology/Oncology, Montreal Children's Hospital of the McGill University Health Centre (RI-MUHC), 1001, Decarie Blvd, Montreal, Québec, H4A 3 J1, Canada., Thomas C; Institute of Neuropathology, University Hospital Münster, 48149, Münster, Germany., Sill M; Hopp Children's Cancer Center at the NCT Heidelberg (KiTZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany., Capper D; Department of Neuropathology, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Charitéplatz 1, 10117, Berlin, Germany.; German Cancer Consortium (DKTK), Partner Site Berlin, Invalidenstrasse 80, 10117, Berlin, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany., Hasselblatt M; Institute of Neuropathology, University Hospital Münster, 48149, Münster, Germany., Malkin D; Genetics and Genome Biology Program, Hospital for Sick Children, PGCRL, 686 Bay Street, Toronto, Ontario, M5G 0A4, Canada. david.malkin@sickkids.ca.; Division of Hematology/Oncology, Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, M5G 1X8, Canada. david.malkin@sickkids.ca.; Department of Pediatrics, Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, M5G 1X8, Canada. david.malkin@sickkids.ca.; Department of Medical Biophysics, University of Toronto, Princess Margaret Cancer Research Tower, MaRS Centre, 101 College Street, Toronto, Ontario, M5G 1 L7, Canada. david.malkin@sickkids.ca.
Publikováno v:
Clinical epigenetics [Clin Epigenetics] 2019 Oct 21; Vol. 11 (1), pp. 144. Date of Electronic Publication: 2019 Oct 21.